of aflatoxin B 1 8,9-epoxide, a highly reactive electrophile Activation of ras proto-oncogenes occurs frequently in vivo capable of forming adducts with DNA and RNA (3, 4) . Reaction in chemically induced rodent tumours, including rat occurs almost exclusively at the N 7 position of guanine (5) . hepatomas induced by aflatoxin B 1 . This study examines In humans, evidence has been obtained from two geothe in vitro activation of a human ras gene by this mycotoxin.
graphical areas of high primary liver cancer incidence and A plasmid containing the human Ha-ras proto-oncogene, aflatoxin exposure that a significant percentage of the hepatotogether with a neomycin resistance gene (pECneo), was cellular carcinomas contained mutated p53 genes, with the incubated in vitro with a microsomal system generating mutations clustered in codon 249 (6, 7) . In 58% of hepatocelluaflatoxin B 1 8,9-epoxide. Subsequent transfection of the lar carcinomas from Qidong province in China, an area of plasmid into mouse NIH 3T3 fibroblasts, followed by high AFB 1 contamination, an AGG→AGT transversion in G418 selection and s.c. injection of surviving cells into codon 249 was detected, a mutation rarely seen in primary immunodeficient mice demonstrated that the proto-oncoliver cancers in western countries (8) . However, no p53 gene had acquired transforming capacity. Although a single mutations in codon 249 were found in AFB 1 -induced hepatotumour resulted from similar treatment of incubated unconcellular carcinomas in non-human primates; only one animal jugated plasmid, no tumours were produced by a secondary in a group of nine had a p53 mutation, a G→T transversion round of transfections using DNA from this tumour. Selectin codon 175 (9) .
ive PCR amplification of the human Ha-ras gene in
No mutations in codon 243 of the p53 gene, which extracted tumour DNA followed by sequencing demoncorresponds to codon 249 in humans, have been detected in strated the presence of G→T transversions either at the AFB 1 -induced pre-neoplastic liver lesions in the AFB 1 -first or middle base of codon 12 in tumours resulting sensitive male F344 rat (10) , but high incidences of activated from transfection with the aflatoxin-B 1 -modified pECneo Ki-ras (11) have been reported in AFB 1 -induced liver tumours plasmid, but this was not detected in the single tumour in these rats, with significant incidences of activated Nresulting from transfection with the unmodified plasmid.
ras (12, 13) . The mutations predominantly involved a G→A Thus, although a mutation in the Ha-ras gene has not transition in codon 12 (11) (12) (13) , with a much lower incidence been reported for human primary hepatomas occurring of G→T transversions in that codon (11) . No mutations were in aflatoxin-exposed populations, metabolically activated observed in codon 61, in contrast to the situation in mice, aflatoxin B 1 is capable of mutating this proto-oncogene to where pre-neoplastic liver lesions induced by a single adminisits oncogenic form in vitro. No mutations were observed in tration of AFB 1 at 7 days of age contained mutations in codon codon 61. It appears that, in contrast to the frequently 61 of the Ha-ras gene (14) . reported G→T transversions in codon 249 of the p53 gene It appears from the data available at present that in humans, in primary hepatomas in aflatoxin-exposed humans, the non-human primates and rats, but not in mice, the mutagenic failure to detect Ha-ras mutations in these tumours is not lesions present in the DNA of hepatic tumours in whose due to an inability of aflatoxin B 1 to activate this protoinitiation AFB 1 is known or is suspected to be involved are oncogene. The G→T transversions observed in this study consistent with interaction of AFB 1 with guanine. However, contrast with the most frequent aflatoxin B 1 in vivo induced in humans this is normally expressed in the tumours as G→T mutations, G→A transitions in the rat Ki-ras gene. Possible transversions in p53, whereas in the rat the interaction is mechanisms for these differences are discussed.
predominantly reflected in G→A transitions in codon 12 of the Ki-ras or N-ras genes.
In view of these striking species differences in the oncogenic Introduction mutations involving the same carcinogen, AFB 1 , it appeared Exposure to dietary aflatoxins, through the consumption of to be of interest to examine the activation of a proto-oncogene stored foodstuffs infected with Aspergillus, has been implicated by AFB 1 in vitro. Because of the somewhat anomalous activation of the Ha-ras gene in the mouse, not involving a guanine base mutation, and also the absence of AFB 1 -associated The total cell population from each of the three plates (~10 6 cells), after Plasmids trypsinization, was resuspended in 300 µl DMEM and each cell suspension The plasmids used in this study were a generous gift from Dr C.J.Marshall injected s.c. at a single site into a nude mouse. No G418-resistant colonies of (Institute of Cancer Research, London, UK). They were: (i) pEJneo, which NIH 3T3 cells were evident in the plasmid-free controls and this control contained the transforming BamHI fragment of the c-Ha-ras-1 oncogene, therefore was not further proceeded with. Resistant colonies were present in cloned from the EJ/T 24 human bladder carcinoma cell line, together with a the cultures of cells transfected with plasmid from the minus-AFB 1 incubation neomycin resistance gene, inserted into pBR 322; (ii) pECneo, which contained controls and these cells were allowed to proliferate. These colonies, however, the 6.6 kb BamHI fragment of the human non-transformed proto-oncogene cgrew much more slowly than those obtained from the G418-resistant cells Ha-ras-1 together with the neomycin resistance gene; (iii) pSV 2 neo, which transfected with the DNA samples isolated following incubation of the pECneo contained only the neomycin resistance gene. For further details of these plasmid in the presence of AFB 1 . All transfectants were allowed to grow to constructs see Marshall et al. (15) .
the same degree of near confluency before injection into nude mice, which represented a total time difference of~1 week (18) . Plasmid pEJneo was Modification of pECneo with metabolically activated AFB 1 transfected into NIH 3T3 cells and used as a positive tumourigenic control. Plasmid pECneo (10 µg) was incubated in 0.8 M potassium phosphate buffer, The animals were examined at regular intervals for the development of pH 7.4, in the presence of quail liver microsomal suspension (equivalent to tumours following injection of transfected, G418-resistant NIH 3T3 cells into 250 µg microsomal protein), an NADPH generating system and [ 3 H]AFB 1 nude mice. The time of first detection of each tumour was noted. They were (1 µg/2.5 µCi) in 5 µl dimethylsulphoxide for 15 min at 37°C. The microsomal excised when they reached a diameter of~0.75 cm. These tumours were snapsuspension was added following a 2 min pre-incubation of the other components frozen in liquid N 2 and subsequently used for the preparation of DNA using of the incubation mixture. The incubations were carried out essentially as the phenol extraction procedure. DNA samples from each of the individual previously described (16) . At the end of the incubation period the tubes were tumours were used in secondary and tertiary rounds of transfection into NIH chilled in ice and a solution containing 100 µg high molecular weight mouse 3T3 cells, being co-transfected with plasmid pSV 2 neo, followed by G418 DNA in potassium phosphate buffer was added. DNA was subsequently selection, growth of surviving cells and injection into nude mice as detailed extracted from the incubation medium by the phenol method, redissolved in above. DNA samples from the tumours were used individually and not pooled. buffer and treated successively with proteinase K and RNase, followed by Initial experiments in which unmodified plasmids pEJneo and pECneo were further extractions with phenol/chloroform. Extracted DNA was redissolved transfected into NIH 3T3 cells, followed by G418 selection and injection into in buffer and an aliquot subjected to electrophoresis on a 0.8% agarose gel.
groups of six nude mice confirmed the tumourigenicity of plasmid pEJneo The plasmid, located under UV light by comparison with a co-electrophoresed and absence of tumourigenicity of plasmid pECneo. The failure of tumours sample of untreated plasmid, was quantitated by comparison with DNA to develop within 9 months in those animals injected with the pECneostandards on the gel. The plasmid extracted following incubation electrotransfected cells indicated a satisfactorily low level of spontaneous transformaphoresed to the same position as the unreacted plasmid with little loss of tion in the NIH 3T3 cells used or spontaneous transforming mutation in sharpness of the band. This indicated that if nucleases were present in the plasmid pECneo. microsomal fraction, no extensive degradation of the plasmid had occurred Southern blotting under the conditions and time of incubation used. Areas of gel containing the plasmid were cut out, dissolved in HCl overnight and radioactivity Samples of individual tumour and NIH 3T3 DNA (~25 µg) were digested determined by liquid scintillation counting. The tumourigenicity of the AFB 1 -with EcoRI restriction nuclease overnight at 37°C and subjected to electrophormodified plasmid was assayed by transfection into NIH 3T3 cells. The extent esis on a 0.8% agarose gel. The gel was denatured prior to blotting onto a of DNA modification by AFB 1 indicated the presence of~1 AFB 1 molecule/ Hybond N membrane using a Stratagene Pressure Blotter, followed by baking 10 000 DNA bases. Control incubations omitting AFB 1 or plasmid were also at 80°C for 30 min. Membranes were probed for Ha-, Ki-and N-ras sequences carried out.
using the appropriate probes (BS9 Ha-ras, p BRN 1.0 N-ras and Hi Hi 380 Ki-ras), labelled with [ 32 P]dCTP using a Stratagene random primer kit. The Transfection and tumourigenicity assays hybridizing conditions were essentially as previously described (13) . Probes DNA samples containing the plasmid obtained following the individual in vitro were purified by passage through a Sephadex G50 column before addition to incubations with metabolically activated AFB 1 carried out as above, together the hybridization mixture. Hybridization was carried out at 42°C for 24 h. with high molecular weight mouse DNA, were transfected into three 100 mm Filters, after washing as previously described (13), were exposed to X-ray diameter culture plates of NIH 3T3 cells per DNA preparation, using the film at -70°C for 6 days. calcium phosphate precipitation method (17) . The cells were grown in PCR and sequencing of DNA Dulbecco's modified Eagle's medium (DMEM) under an atmosphere of 10% CO 2 . Cells were trypsinized off the plates after 48 h and replated in medium DNA (~200 ng) extracted from individual primary, secondary and tertiary tumours and plasmids pECneo and pEJneo was amplified using primers containing G418 (1 mg/ml). Following the extensive reduction in cell number due to sensitivity to G418 toxicity of the majority of cells, the few remaining appropriate to the human Ha-ras gene. Tumour DNA samples were not pooled. The protocol used is detailed in Figure 1 . A Perkin-Elmer-Cetus cells (Ͻ1%) subsequently resumed dividing and were allowed to grow to near extracted from the single tumour, P 2 A, which resulted from finally 67°C for 1 min, followed by 70°C for 10 min. The forward primer for P 2 DNA (plasmid without AFB 1 ), but no tumours resulted exon 1 was combined with a reverse primer for exon 2 in the amplification, from secondary transfections using this DNA. Series P 1 A, P 1 B producing an amplified fragment of~520 bp in length which was purified by binding to Qiagen, followed by elution, using the manufacturer's protocol.
and P 1 C transfectants showed increasing tumourigenicity on
This removed residual primers and other contaminating materials, including successive transfections.
unincorporated nucleotides, Taq polymerase and mineral oil. This process
Southern blotting
facilitated the subsequent sequencing procedure. The sequencing was carried out using a Sequenase version 2 kit, with a forward primer to the complementary DNA from NIH 3T3 cells, primary tumour P 1 A, three secondary strand for human Ha-ras exon 2 (including codon 61), resulting in the coding tumour samples P 1 AA and two tertiary tumours P 1 AAA were sequence, and a reverse primer to the coding strand for human Ha-ras exon digested with EcoRI, subjected to electrophoresis in 0.8% 1 (including codons 12 and 13), resulting in the non-coding sequence (see Figure 1 ).
agarose, blotted and hybridized with probes for Ha-, N-and Ki-ras. Bands extra to NIH 3T3 DNA were observed using the Ha-ras (BS9) probe (Figure 2 ), but not with the N-and Results Ki-ras probes. Similar results were obtained from primary, Reaction of pECneo with activated AFB 1 and acquisition of secondary and tertiary tumours from the P 1 B and P 1 C series transforming capacity of tumours (results not shown). The DNA extracted from the The incubation conditions used resulted in a modification of single tumour, P 2 A, which arose after 7 months from the NIH plasmid pECneo to the extent of~1 AFB 1 molecule/10 000 3T3 cells transfected with the pECneo control (minus-AFB 1 ) DNA bases, with no evidence of significant degradation due also showed extra Ha-ras bands on Southern blotting. The to microsomal nuclease activity. The three incubation groups pattern, however, was unlike those detected in the series of used were designated P 1 (plasmid ϩ AFB 1 ), P 2 (plasmid tumours P 1 A, P 1 B or P 1 C (data not shown). No tumours arose without AFB 1 ) and P 3 (AFB 1 without plasmid). When DNA in animals injected with secondary NIH 3T3 transfectants of samples from these incubations (in the case of P 3 consisting the P 2 A tumour DNA. only of the high molecular weight mouse DNA added at the end of the incubation period) were transfected into NIH 3T3 cells as detailed above, only P 1 and P 2 samples resulted in G418-resistant cells. These were grown on and injected into nude mice. Tumours were obtained as detailed in Table I . DNA was extracted from all three P 1 tumours (P 1 A, P 1 B and P 1 C) and the single P 2 tumour (P 2 A). This DNA was then used in a secondary round of transfections into NIH 3T3 cells, together with plasmid PSV 2 neo, one plate of cells per tumour DNA sample. After G418 selection, surviving cells were allowed to resume growth and were replated. Cells transfected with tumour sample P 1 A, which grew quickly, were replated into six dishes and P 1 B and P 1 C samples, which grew somewhat Table I . ---, NIH 3T3 DNArelated band; ---, non-NIH 3T3 DNA-related bands.
transfections (P 1 AA, etc.) and a subsequent tertiary round of a G→T transversion at the middle base of codon 12 (GTC), the same mutation as that present in plasmid pEJneo. The codon 12 mutation detected in P 1 B (GTC) was conserved in the secondary and tertiary transfectants derived from it. Technical difficulties were encountered in attempts to subject P 1 C to PCR and no amplified DNA was obtained from this tumour. The secondary and tertiary transfectants from this series (P 1 CC 1-3 and P 1 CCC 1-3 ) contained the first base G→T codon 12 transversion observed in the P 1 A series. In no case of primary, secondary or tertiary tumours was a mutation detected in codon 61. The sequences obtained for the PCR products for both codons 12 and 61 corresponded to the sequences for human and not mouse Ha-ras (indicated in Table II ), demonstrating that the results represented mutations in the transfected pEC plasmid and not in the mouse genomic Haras gene. P 2 A DNA contained no mutations in codons 12 or 61.
Discussion
The results obtained in this study, in that of Marshall et al. the human Ha-ras proto-oncogene, to demonstrate not only mutational but also transforming and carcinogenic potential. The flexibility of this method as an in vitro test system is also illustrated by the finding that a significant proportion of the mutations induced by BPDE were in codon 12 (15) , probably due to G→T transversions, whereas all the activating mutations resulting from active oxygen species were A→T transversions at the second base of codon 61 (19) .
Since a wide range of carcinogenic chemicals are known to exert their effects through activation of ras genes, this in vitro test system appears highly appropriate. A further point of interest is that neither AFB 1 nor benzo [a] pyrene have been demonstrated to activate the Ha-ras gene in in vivo experimental animal systems. The actual initiating carcinogenic mutations resulting from administration of these chemicals, therefore, are probably determined by in vivo factors which relate to species differences and target organ specificity within a species.
In terms of the specific mechanism of AFB 1 -induced mutations, a major point of interest in the present series of experiments was to determine if activated AFB 1 could cause the Ha-ras proto-oncogene to acquire transforming capacity, mouse. A clear limitation in the study was the restricted number of nude mice available and this has permitted only Sequencing of tumour DNAs somewhat tentative conclusions to be drawn. However, it does appear evident from the present results that activation of the Sequencing was carried out using samples of DNA from individual tumours following amplification by PCR. Plasmids human Ha-ras gene by AFB 1 is potentially possible, from a biochemical mechanistic viewpoint. In contrast to the mouse pECneo and pEJneo were used as standards. Examples of the sequencing gels are given in Figures 3 and 4 and the data are treated in vivo at the neonate stage with AFB 1 , where nonguanine-related codon 61 mutations were observed, albeit in summarized in Table II . The known mutation present in codon 12 of pEJneo (GTC) compared with the wild-type codon 12 a very small number of samples (two hepatomas and one adenoma; 14) , in the in vitro activated AFB 1 pECneo system in pECneo (GGC) was demonstrated. The sequence obtained with DNA from the P 1 A tumour revealed the presence of both mutations at guanine bases were involved. The mouse is normally highly resistant to the toxic and carcinogenic effect wild-type codon 12 and a first base G→T transversion in that codon (TGC). This mutated codon 12 was detected in of AFB 1 in vivo, which is related to a high level of AFB 1 8,9-epoxide conjugating activity dependent on glutathione Sall of the secondary and tertiary tumours derived from P 1 A (P 1 AA 1-6 and P 1 AAA 1-6 ), but the wild-type codon was transferase isoenzymes (20, 21 ), resulting in a low level of interaction of AFB 1 with DNA. It would be of interest to not observed in any of these subsequent tumours. P 1 B contained Table II . Sequencing of portions of Ha-ras know if the low level of interaction of AFB 1 with DNA in of the AFB 1 -DNA adducts being in the ring-opened FAPY form at the time of transfection of the plasmid into NIH 3T3 species resistant to aflatoxin B 1 (e.g. the mouse) involved formation of higher proportions of non-guanine adducts and cells. If this occurred at the first or second base of codon 12, G→T transversions could result, both of which are known to perhaps a greater persistence of such adducts than in sensitive species. Work is in progress examining this feature.
be transforming mutations. It is statistically probable that these mutations would be present in an extremely small fraction of In vivo in the rat high levels of Ki-and N-ras activation have been found to be present in AFB 1 -induced pre-neoplastic the incubated plasmid, since interactions at other bases would either be ineffective or more probably would negate the effect and neoplastic lesions (11) (12) (13) , with guanine being virtually exclusively the DNA base involved. The mutations have of a concomitantly formed, potentially activating mutation in codon 12. This presumably is the basis for the loss of the largely been G→A transitions, which suggests that loss of AFB 1 -N 7 -guanine, resulting in an apurinic site, was followed transforming potential of plasmid pEJneo observed by Marshall et al. (15) when higher levels of modification of the plasmid by inappropriate replacement of G by A. Presumably this transition took place before replication of the codon had with BPDE were induced. The rarity of the exclusive, mutationally effective alteration in codon 12 in the in vitro incubaoccurred. A considerably lower incidence of G→T transversions was observed in AFB 1 -induced rat liver lesions (11) .
tions probably accounts for the interesting, but perhaps fortunate, finding that the two tumour lines examined in this It has been suggested that transversion mutations could result from replication of a bulky DNA adduct (22), probably study in the absence of cloning of the original transfected NIH 3T3 cells nevertheless had distinct and different base alterations as a consequence of mispairing at the time of replication of an AFB 1 -DNA adduct. However, in view of the limited halfin codon 12. Further studies are clearly necessary to examine this point. life of the AFB 1 -N 7 -guanine adduct in DNA (5), it is perhaps more likely that it represents mispairing due to the presence The presence of both mutant and wild-type human Ha-ras codon 12 sequences in the primary tumour P 1 A was probably of the more persistent, stable ring-opened form of the AFB 1 adduct, 8,9-dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyridue to a high percentage of the G418-selected cells not carrying the mutation, coupled with a limited capacity for growth of mid-5-yl formamido)-9-hydroxy AFB 1 (AFB 1 -FAPY). The present study did not reveal any mutations due to transitions; cells carrying the non-transforming sequence in the presence of transformed cells on transfection. The wild-type sequence, all three of the persistent mutations observed involved G→T transversions. No DNA repair activity would have taken place however, was not detected in any of the subsequent transfectants in this series. in the in vitro incubation systems used in the present study and so the ring-opened AFB 1 -FAPY adducts would have
In humans, p53 mutations are related to G→T tranversions, probably reflecting replication of bulky AFB 1 -DNA adducts. persisted. The present data thus could support AFB 1 -FAPYrelated mispairing mutations, since extraction of the AFB 1 -
The involvement of guanine base-related AFB 1 -induced mutations in hepatic carcinogenesis in both rat and man modified plasmid DNA and subsequent incubation in neutral pH solutions would have resulted in a considerable proportion indicates that, despite the differences in the actual genes
